References
Flechsig P, Mehndiratta A, Haberkorn U, Kratochwil C, Giesel FL. PET/MRI and PET/CT in lung lesions and thoracic malignancies. Semin Nucl Med. 2015;45(4):268–81. https://doi.org/10.1053/j.semnuclmed.2015.03.004.
Lindner T, Loktev A, Altmann A, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59(9):1415–22. https://doi.org/10.2967/jnumed.118.210443.
Loktev A, Lindner T, Mier W, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59(9):1423–9. https://doi.org/10.2967/jnumed.118.210435.
Giesel F, Kratochwil C, Lindner T, et al. FAPI-PET/CT: biodistribution and preliminary dosimetry estimate of two DOTA-containing FAP-targeting agents in patients with various cancers. J Nucl Med. 2019;60(3):386–392. https://doi.org/10.2967/jnumed.118.215913.
Kratochwil C, Flechsig P, Lindner T, et al. FAPI-PET/CT: mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer. J Nucl Med 2019 6. doi: https://doi.org/10.2967/jnumed.119.227967.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Informed consent and ethical approval
The radiopharmaceutical was used on an individual patient basis according to German Pharmaceuticals Act §13(2b). The patient gave written informed consent to receive the novel diagnostics and permitted anonymized publication of related medical data. The ethical committee of Heidelberg University approved this retrospective evaluation to be in accordance with the Helsinki declaration (permit S016/2018). For case reports from clinical practice no trial registration is required.
Disclosure of potential conflicts of interest
Giesel FL, Lindner T, Haberkorn U, Kratochwil C have a patent application for quinolone-based radiolabeled FAPI-ligands. The other authors have no conflict of interest to declare.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Image of the Month.
Rights and permissions
About this article
Cite this article
Giesel, F.L., Heussel, C.P., Lindner, T. et al. FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis. Eur J Nucl Med Mol Imaging 46, 1754–1755 (2019). https://doi.org/10.1007/s00259-019-04346-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-019-04346-z